{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:33:33Z","timestamp":1772138013248,"version":"3.50.1"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:00:00Z","timestamp":1640649600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The pharmacological arsenal against the COVID-19 pandemic is largely based on generic anti-inflammatory strategies or poorly scalable solutions. Moreover, as the ongoing vaccination campaign is rolling slower than wished, affordable and effective therapeutics are needed. To this end, there is increasing attention toward computational methods for drug repositioning and de novo drug design.<\/jats:p>\n                  <jats:p>Here, multiple data-driven computational approaches are systematically integrated to perform a virtual screening and prioritize candidate drugs for the treatment of COVID-19. From the list of prioritized drugs, a subset of representative candidates to test in human cells is selected. Two compounds, 7-hydroxystaurosporine and bafetinib, show synergistic antiviral effects in vitro and strongly inhibit viral-induced syncytia formation. Moreover, since existing drug repositioning methods provide limited usable information for de novo drug design, the relevant chemical substructures of the identified drugs are extracted to provide a chemical vocabulary that may help to design new effective drugs.<\/jats:p>","DOI":"10.1093\/bib\/bbab507","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T08:15:48Z","timestamp":1636100148000},"source":"Crossref","is-referenced-by-count":16,"title":["Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-1492","authenticated-orcid":false,"given":"Angela","family":"Serra","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"BioMediTech Institute, Tampere University, Tampere, Finland"},{"name":"Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3997-2339","authenticated-orcid":false,"given":"Michele","family":"Fratello","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"BioMediTech Institute, Tampere University, Tampere, Finland"},{"name":"Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2554-9879","authenticated-orcid":false,"given":"Antonio","family":"Federico","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"BioMediTech Institute, Tampere University, Tampere, Finland"},{"name":"Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7876-4607","authenticated-orcid":false,"given":"Ravi","family":"Ojha","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-1924","authenticated-orcid":false,"given":"Riccardo","family":"Provenzani","sequence":"additional","affiliation":[{"name":"Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland"}]},{"given":"Ervin","family":"Tasnadi","sequence":"additional","affiliation":[{"name":"Synthetic and Systems Biology Unit, Biological Research Centre, Eotvos Lorand Research Network, Szeged, Hungary"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-2310","authenticated-orcid":false,"given":"Luca","family":"Cattelani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"BioMediTech Institute, Tampere University, Tampere, Finland"},{"name":"Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-4796","authenticated-orcid":false,"given":"Giusy","family":"del Giudice","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"BioMediTech Institute, Tampere University, Tampere, Finland"},{"name":"Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-5331","authenticated-orcid":false,"given":"Pia A S","family":"Kinaret","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"BioMediTech Institute, Tampere University, Tampere, Finland"},{"name":"Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland"},{"name":"Institute of Biotechnology, University of Helsinki, Helsinki, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1996-286X","authenticated-orcid":false,"given":"Laura A","family":"Saarim\u00e4ki","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"BioMediTech Institute, Tampere University, Tampere, Finland"},{"name":"Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-0214","authenticated-orcid":false,"given":"Alisa","family":"Pavel","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"BioMediTech Institute, Tampere University, Tampere, Finland"},{"name":"Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2347-5397","authenticated-orcid":false,"given":"Suvi","family":"Kuivanen","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-3796","authenticated-orcid":false,"given":"Vincenzo","family":"Cerullo","sequence":"additional","affiliation":[{"name":"Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2270-6824","authenticated-orcid":false,"given":"Olli","family":"Vapalahti","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland"},{"name":"Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland"},{"name":"Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"}]},{"given":"Peter","family":"Horvath","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"},{"name":"Synthetic and Systems Biology Unit, Biological Research Centre, Eotvos Lorand Research Network, Szeged, Hungary"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0265-7554","authenticated-orcid":false,"given":"Antonio Di","family":"Lieto","sequence":"additional","affiliation":[{"name":"Department of Forensic Psychiatry, Aarhus University, Aarhus, Denmark"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0370-7653","authenticated-orcid":false,"given":"Jari","family":"Yli-Kauhaluoma","sequence":"additional","affiliation":[{"name":"Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3585-559X","authenticated-orcid":false,"given":"Giuseppe","family":"Balistreri","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland"},{"name":"Queensland Brain Institute, The University of Queensland, Brisbane, Australia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9195-9003","authenticated-orcid":false,"given":"Dario","family":"Greco","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"BioMediTech Institute, Tampere University, Tampere, Finland"},{"name":"Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland"},{"name":"Institute of Biotechnology, University of Helsinki, Helsinki, Finland"}]}],"member":"286","published-online":{"date-parts":[[2021,12,27]]},"reference":[{"key":"2022012000315058500_ref1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Thanh Le","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"2022012000315058500_ref2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bsheal.2021.02.001","article-title":"An update to monoclonal antibody as therapeutic option against COVID-19","volume":"3","author":"Deb","year":"2021","journal-title":"Biosaf Health"},{"issue":"1","key":"2022012000315058500_ref3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bj.2020.11.011","article-title":"Neutralizing monoclonal antibodies for COVID-19 treatment and prevention","volume":"44","author":"Jaworski","year":"2020","journal-title":"Biomed J"},{"key":"2022012000315058500_ref4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/pai.13271","article-title":"The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures","volume":"31","author":"Matricardi","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"2022012000315058500_ref5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2022012000315058500_ref6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"2022012000315058500_ref7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3389\/fphar.2020.01196","article-title":"COVID-19 therapeutic options under investigation","volume":"11","author":"Kaddoura","year":"2020","journal-title":"Front Pharmacol"},{"key":"2022012000315058500_ref8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41421-020-00221-6","article-title":"Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients","volume":"6","author":"Yan","year":"2020","journal-title":"Cell Discov"},{"key":"2022012000315058500_ref9","first-page":"e10480","article-title":"Therapeutic options for COVID-19: a review","volume":"12","author":"Pujari","year":"2020","journal-title":"Cureus"},{"key":"2022012000315058500_ref10","doi-asserted-by":"crossref","first-page":"104362","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J Clin Virol"},{"key":"2022012000315058500_ref11","doi-asserted-by":"crossref","DOI":"10.4081\/monaldi.2020.1300","article-title":"COVID-19 and coagulative axis: review of emerging aspects in a novel disease","volume":"90","author":"Boccia","year":"2020","journal-title":"Monaldi Arch Chest Dis"},{"key":"2022012000315058500_ref12","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/bib\/bbaa417","article-title":"Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment","volume":"22","author":"Pavel","year":"2021","journal-title":"Brief Bioinform"},{"key":"2022012000315058500_ref13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit Care"},{"key":"2022012000315058500_ref14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cegh.2020.07.006","article-title":"Antivirals for COVID-19: a critical review","volume":"9","author":"Frediansyah","year":"2021","journal-title":"Clin Epidemiol Global Health"},{"key":"2022012000315058500_ref15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jiph.2020.07.013","article-title":"Clinical efficacy of antivirals against novel coronavirus (COVID-19): a review","volume":"13","author":"Jomah","year":"2020","journal-title":"J Infect Public Health"},{"key":"2022012000315058500_ref16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00705-020-04693-5","article-title":"The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review","volume":"165","author":"Lima","year":"2020","journal-title":"Arch Virol"},{"key":"2022012000315058500_ref17","doi-asserted-by":"crossref","first-page":"e00864","DOI":"10.1016\/j.idcr.2020.e00864","article-title":"Doxycycline as a potential partner of COVID-19 therapies","volume":"21","author":"Malek","year":"2020","journal-title":"IDCases"},{"key":"2022012000315058500_ref18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ddr.21762","article-title":"Review of registered clinical trials for the treatment of COVID-19","volume":"82","author":"Babaei","year":"2021","journal-title":"Drug Dev Res"},{"key":"2022012000315058500_ref19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1758-2946-5-30","article-title":"Drug repositioning: a machine-learning approach through data integration","volume":"5","author":"Napolitano","year":"2013","journal-title":"J Chem"},{"key":"2022012000315058500_ref20","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftaa036","article-title":"Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19)","volume":"78","author":"Jia","year":"2020","journal-title":"Pathog Dis"},{"key":"2022012000315058500_ref21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00210-020-01901-6","article-title":"A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)","volume":"393","author":"Rameshrad","year":"2020","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2022012000315058500_ref22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/bib\/bbaa288","article-title":"A review on drug repurposing applicable to COVID-19","volume":"22","author":"Dotolo","year":"2021","journal-title":"Brief Bioinform"},{"key":"2022012000315058500_ref23","doi-asserted-by":"crossref","DOI":"10.21203\/rs.3.rs-23951\/v1","volume-title":"Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection","author":"Ellinger","year":"2020"},{"key":"2022012000315058500_ref24","article-title":"Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2","author":"Heiser","year":"2020","journal-title":"BioRxiv"},{"key":"2022012000315058500_ref25","doi-asserted-by":"crossref","first-page":"13093","DOI":"10.1038\/s41598-020-70143-6","article-title":"In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication","volume":"10","author":"Touret","year":"2020","journal-title":"Sci Rep"},{"key":"2022012000315058500_ref26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"2022012000315058500_ref27","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1021\/jm301916b","article-title":"Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis","volume":"56","author":"Zhu","year":"2013","journal-title":"J Med Chem"},{"key":"2022012000315058500_ref28","first-page":"45","article-title":"Anticancer natural products","volume":"55","author":"Sarker","year":"2020","journal-title":"Med Nat Prod"},{"key":"2022012000315058500_ref29","doi-asserted-by":"crossref","first-page":"12310","DOI":"10.1038\/s41598-021-91625-1","article-title":"Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19","volume":"11","author":"Le","year":"2021","journal-title":"Sci Rep"},{"key":"2022012000315058500_ref30","doi-asserted-by":"crossref","first-page":"104610","DOI":"10.1016\/j.meegid.2020.104610","article-title":"A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection","volume":"86","author":"Mousavi","year":"2020","journal-title":"Infect Genet Evol"},{"key":"2022012000315058500_ref31","doi-asserted-by":"crossref","first-page":"545089","DOI":"10.3389\/fcell.2020.545089","article-title":"Designing a network proximity-based drug repurposing strategy for COVID-19","volume":"8","author":"Stolfi","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2022012000315058500_ref32","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1080\/07391102.2020.1794971","article-title":"Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants","volume":"39","author":"Fatoki","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"2022012000315058500_ref33","doi-asserted-by":"crossref","first-page":"e2000113","DOI":"10.1002\/minf.202000113","article-title":"QSAR modeling of SARS-CoV Mpro inhibitors identifies sufugolix, cenicriviroc, proglumetacin, and other drugs as candidates for repurposing against SARS-CoV-2","volume":"40","author":"Alves","year":"2020","journal-title":"Mol Inform"},{"key":"2022012000315058500_ref34","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"2022012000315058500_ref35","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/bib\/bbx017","article-title":"A review of network-based approaches to drug repositioning","volume":"19","author":"Lotfi Shahreza","year":"2018","journal-title":"Brief Bioinform"},{"key":"2022012000315058500_ref36","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/s41467-018-05116-5","article-title":"Network-based approach to prediction and population-based validation of in silico drug repurposing","volume":"9","author":"Cheng","year":"2018","journal-title":"Nat Commun"},{"key":"2022012000315058500_ref37","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"2022012000315058500_ref38","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2022012000315058500_ref39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/med.21728","article-title":"COVID-19 drug repurposing: a review of computational screening methods, clinical trials, and protein interaction assays","volume":"41","author":"Wang","year":"2020","journal-title":"Med Res Rev"},{"key":"2022012000315058500_ref40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11095-020-02851-7","article-title":"Repurposing of kinase inhibitors for treatment of COVID-19","volume":"37","author":"Weisberg","year":"2020","journal-title":"Pharm Res"},{"key":"2022012000315058500_ref41","article-title":"Drug repurposing for COVID-19 using computational screening: Is Fostamatinib\/R406 a potential candidate","volume-title":"Methods","author":"Saha","year":"2021"},{"key":"2022012000315058500_ref42","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.2147\/DDDT.S282252","article-title":"Repurposing anti-cancer drugs for COVID-19 treatment","volume":"14","author":"Borcherding","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"2022012000315058500_ref43","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41416-020-0948-x","article-title":"Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy","volume":"123","author":"Saini","year":"2020","journal-title":"Br J Cancer"},{"key":"2022012000315058500_ref44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41586-021-03491-6","article-title":"Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia","volume":"594","author":"Braga","year":"2021","journal-title":"Nature"},{"key":"2022012000315058500_ref45","doi-asserted-by":"crossref","first-page":"eabd0110","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci Immunol"},{"key":"2022012000315058500_ref46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"key":"2022012000315058500_ref47","doi-asserted-by":"crossref","first-page":"16862","DOI":"10.1038\/s41598-019-53239-6","article-title":"The DOT1L inhibitor Pinometostat decreases the host-response against infections: considerations about its use in human therapy","volume":"9","author":"Marcos-Villar","year":"2019","journal-title":"Sci Rep"},{"key":"2022012000315058500_ref48","doi-asserted-by":"crossref","first-page":"103104","DOI":"10.1016\/j.ebiom.2020.103104","article-title":"Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology","volume":"61","author":"Bussani","year":"2020","journal-title":"EBioMedicine"},{"key":"2022012000315058500_ref49","doi-asserted-by":"crossref","first-page":"e1453","DOI":"10.1016\/S2214-109X(20)30444-7","article-title":"COVID-19 pneumonia and the appropriate use of antibiotics","volume":"8","author":"Ginsburg","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2022012000315058500_ref50","doi-asserted-by":"crossref","first-page":"16577","DOI":"10.1038\/s41598-020-73641-9","article-title":"Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir","volume":"10","author":"Jockusch","year":"2020","journal-title":"Sci Rep"},{"key":"2022012000315058500_ref51","volume-title":"Drug repurposing of approved drugs elbasvir, ledipasvir, paritaprevir, velpatasvir, antrafenine and ergotamine for combating COVID19","author":"Mevada","year":"2020"},{"key":"2022012000315058500_ref52","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.arcmed.2020.06.004","article-title":"Could respiratory fluoroquinolones, levofloxacin and Moxifloxacin, prove to be beneficial as an adjunct treatment in COVID-19?","volume":"51","author":"Karampela","year":"2020","journal-title":"Arch Med Res"},{"key":"2022012000315058500_ref53","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"2022012000315058500_ref54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1006313611677","article-title":"UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines","volume":"18","author":"Monks","year":"2000","journal-title":"Invest New Drugs"},{"key":"2022012000315058500_ref55","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1158\/1078-0432.CCR-04-2602","article-title":"The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trial","volume":"11","author":"Lara","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022012000315058500_ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2401994","article-title":"Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies","volume":"15","author":"Senderowicz","year":"2001","journal-title":"Leukemia"},{"key":"2022012000315058500_ref57","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1182\/blood-2005-08-3351","article-title":"Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial","volume":"107","author":"Sampath","year":"2006","journal-title":"Blood"},{"key":"2022012000315058500_ref58","first-page":"1450","article-title":"Bafetinib, a dual Bcr-Abl\/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia","volume":"11","author":"Santos","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"2022012000315058500_ref59","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1126\/science.abg5827","article-title":"Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2","volume":"373","author":"Drayman","year":"2021","journal-title":"Science"},{"key":"2022012000315058500_ref60","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The global phosphorylation landscape of SARS-CoV-2 infection","volume":"182","author":"Bouhaddou","year":"2020","journal-title":"Cell"},{"key":"2022012000315058500_ref61","article-title":"TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells","volume":"40","author":"Koch","year":"2021","journal-title":"EMBO"},{"key":"2022012000315058500_ref62","doi-asserted-by":"crossref","first-page":"e0097521","DOI":"10.1128\/JVI.00975-21","article-title":"Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease","volume":"95","author":"Kreutzberger","year":"2021","journal-title":"J Virol"},{"key":"2022012000315058500_ref63","doi-asserted-by":"crossref","first-page":"e107405","DOI":"10.15252\/embj.2020107405","article-title":"Syncytia formation by SARS-CoV-2-infected cells","volume":"40","author":"Buchrieser","year":"2021","journal-title":"EMBO J"},{"key":"2022012000315058500_ref64","doi-asserted-by":"crossref","first-page":"25694","DOI":"10.1038\/srep25694","article-title":"Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"2022012000315058500_ref65","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.placenta.2012.07.016","article-title":"ABC drug transporter and nuclear receptor expression in human cytotrophoblasts: influence of spontaneous syncytialization and induction by glucocorticoids","volume":"33","author":"Manceau","year":"2012","journal-title":"Placenta"},{"key":"2022012000315058500_ref66","doi-asserted-by":"crossref","first-page":"e106267","DOI":"10.15252\/embj.2020106267","article-title":"Syncytia formation by SARS-CoV-2-infected cells","volume":"39","author":"Buchrieser","year":"2020","journal-title":"EMBO J"},{"key":"2022012000315058500_ref67","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"key":"2022012000315058500_ref68","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1099\/jgv.0.001047","article-title":"Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors","volume":"99","author":"Sisk","year":"2018","journal-title":"J Gen Virol"},{"key":"2022012000315058500_ref69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"2022012000315058500_ref70","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.csbj.2021.06.017","article-title":"WADDAICA: a webserver for aiding protein drug design by artificial intelligence and classical algorithm","volume":"19","author":"Bai","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"2022012000315058500_ref71","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1021\/jm5019093","article-title":"PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS","volume":"58","author":"Dahlin","year":"2015","journal-title":"J Med Chem"},{"key":"2022012000315058500_ref72","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"2022012000315058500_ref73","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1038\/s41598-021-86002-x","article-title":"Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway","volume":"11","author":"Daamen","year":"2021","journal-title":"Sci Rep"},{"key":"2022012000315058500_ref74","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1101\/gr.124321.111","article-title":"Differential expression in RNA-seq: a matter of depth","volume":"21","author":"Tarazona","year":"2011","journal-title":"Genome Res"},{"key":"2022012000315058500_ref75","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2022012000315058500_ref76","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol"},{"key":"2022012000315058500_ref77","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B Methodol"},{"key":"2022012000315058500_ref78","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pbio.0050008","article-title":"Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles","volume":"5","author":"Faith","year":"2007","journal-title":"PLoS Biol"},{"key":"2022012000315058500_ref79","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/1471-2105-9-461","article-title":"Minet: a R\/Bioconductor package for inferring large transcriptional networks using mutual information","volume":"9","author":"Meyer","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"2022012000315058500_ref80","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/bioinformatics\/bty063","article-title":"Inform: inference of network response modules","volume":"34","author":"Marwah","year":"2018","journal-title":"Bioinformatics"},{"key":"2022012000315058500_ref81","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/sagmb-2014-0093","article-title":"TopKLists: a comprehensive R package for statistical inference, stochastic aggregation, and visualization of multiple omics ranked lists","volume":"14","author":"Schimek","year":"2015","journal-title":"Stat Appl Genet Mol Biol"},{"key":"2022012000315058500_ref82","doi-asserted-by":"crossref","first-page":"D921","DOI":"10.1093\/nar\/gku955","article-title":"Open TG-GATEs: a large-scale toxicogenomics database","volume":"43","author":"Igarashi","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2022012000315058500_ref83","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2022012000315058500_ref84","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy \u2013 analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"2022012000315058500_ref85","first-page":"33","volume-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Statistics for Biology and Health","author":"Bolstad","year":"2005"},{"key":"2022012000315058500_ref86","article-title":"AnnotationDbi: Manipulation of SQLite-based annotations in Bioconductor","author":"Pag\u00e8s","year":"2020"},{"key":"2022012000315058500_ref87","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giaa055","article-title":"TinderMIX: time-dose integrated modelling of toxicogenomics data","volume":"9","author":"Serra","year":"2020","journal-title":"Gigascience"},{"key":"2022012000315058500_ref88","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2164-8-387","article-title":"BMDExpress: a software tool for the benchmark dose analyses of genomic data","volume":"8","author":"Yang","year":"2007","journal-title":"BMC Genomics"},{"key":"2022012000315058500_ref89","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/toxsci\/kfm092","article-title":"A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure","volume":"98","author":"Thomas","year":"2007","journal-title":"Toxicol Sci"},{"key":"2022012000315058500_ref90","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1093\/bioinformatics\/btaa030","article-title":"BMDx: a graphical shiny application to perform benchmark dose analysis for transcriptomics data","volume":"36","author":"Serra","year":"2020","journal-title":"Bioinformatics"},{"key":"2022012000315058500_ref91","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt","volume":"4","author":"Durinck","year":"2009","journal-title":"Nat Protoc"},{"key":"2022012000315058500_ref92","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/bioinformatics\/bti525","article-title":"BioMart and bioconductor: a powerful link between biological databases and microarray data analysis","volume":"21","author":"Durinck","year":"2005","journal-title":"Bioinformatics"},{"key":"2022012000315058500_ref93","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022012000315058500_ref94","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/bioinformatics\/btv536","article-title":"Drug-set enrichment analysis: a novel tool to investigate drug mode of action","volume":"32","author":"Napolitano","year":"2016","journal-title":"Bioinformatics"},{"key":"2022012000315058500_ref95","doi-asserted-by":"crossref","first-page":"D1302","DOI":"10.1093\/nar\/gkaa1027","article-title":"Open targets platform: supporting systematic drug-target identification and prioritisation","volume":"49","author":"Ochoa","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2022012000315058500_ref96","first-page":"1","article-title":"Principles of QSAR modeling","volume":"5","author":"Gramatica","year":"2020","journal-title":"Int J Quant Struct Prop Relatsh"},{"key":"2022012000315058500_ref97","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2022012000315058500_ref98","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1574-1400(08)00012-1","article-title":"PubChem: integrated platform of small molecules and biological activities","volume":"4","author":"Bolton","year":"2008","journal-title":"Ann Rep Comput Chem"},{"key":"2022012000315058500_ref99","doi-asserted-by":"crossref","first-page":"56","DOI":"10.25080\/Majora-92bf1922-00a","volume-title":"Proceedings of the 9th Python in Science Conference","author":"McKinney","year":"2010"},{"key":"2022012000315058500_ref100","article-title":"Metric distances derived from cosine similarity and Pearson and Spearman correlations","author":"Van Dongen","year":"2012"},{"key":"2022012000315058500_ref101","first-page":"226","article-title":"A density-based algorithm for discovering clusters in large spatial databases with noise","volume":"96","author":"Ester","year":"1996","journal-title":"Kdd"},{"key":"2022012000315058500_ref102","first-page":"2825","article-title":"Scikit-learn: machine learning in python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J Mach Learn Res"},{"key":"2022012000315058500_ref103","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: a gradient boosting machine","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann Statist"},{"key":"2022012000315058500_ref104","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The Elements of Statistical Learning: Data Mining, Inference, and Prediction","author":"Hastie","year":"2009"},{"key":"2022012000315058500_ref105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13321-015-0069-3","article-title":"Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?","volume":"7","author":"Bajusz","year":"2015","journal-title":"J Chem"},{"key":"2022012000315058500_ref106","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"2022012000315058500_ref107","first-page":"265","volume-title":"Proceedings of the 12th USENIX Symposium on Operating Systems Design and Implementation (OSDI\u201916)","author":"Abadi","year":"2016"},{"key":"2022012000315058500_ref108","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1109\/ICCV.2017.322","volume-title":"IEEE International Conference on Computer Vision (ICCV)","author":"He","year":"2017"},{"key":"2022012000315058500_ref109","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1128\/JVI.79.21.13800-13805.2005","article-title":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells","volume":"79","author":"Ziegler","year":"2005","journal-title":"J Virol"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/1\/bbab507\/42231891\/bbab507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/1\/bbab507\/42231891\/bbab507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:33:53Z","timestamp":1726054433000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab507\/6484515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,27]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,17]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab507","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.15.440004","asserted-by":"object"}]},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1]]},"published":{"date-parts":[[2021,12,27]]},"article-number":"bbab507"}}